Table 3.
Associations between excess HS and infant anthropometric outcomes stratified by MNS treatment Arm.
| Outcome | Arm 1 (MNS supplementation) N = 158 | Arm 2 (No MNS supplementation) N = 154 | Arm 3 (No MNS supplementation) N = 139 | |||
|---|---|---|---|---|---|---|
| β (95% CI) | P-value | β (95% CI) | P-value | β (95% CI) | P-value | |
| LGAZ | −0.277 (−0.637, 0.081) | 0.12 | −0.667 (−1.040, −0.294) | 0.0005 | −0.505 (−0.934, −0.082) | 0.01 |
| WGAZ | −0.026 (−0.355, 0.303) | 0.87 | −0.378 (−0.739, 0.016) | 0.04 | −0.095 (−0.443, 0.253) | 0.58 |
| HCGAZ | −0.383 (−0.742, −0.024) | 0.03 | −0.391 (−0.789, 0.006) | 0.05 | −0.398 (−0.845, −0.048) | 0.07 |
Models were adjusted for cluster, maternal age, parity, infant sex, mode of delivery, and maternal weight gain between 12 and 32 wk of pregnancy. Excessive HS was defined as >20 days with Tmax over 39°C in the first trimester. Abbreviations: LGAZ, length-for-age Z-score; WGAZ, weight-for-age Z-score; and HCGAZ, head circumference-for-age Z-score. Samples sizes in HS and non-HS groups were n = 44 and 114 in Arm 1; n = 48 and 106 in Arm 2; and n = 38 and 101 in Arm 3, respectively.